Azek price target raised to $57 from $54 at BMO Capital

Azek price target raised to $57 from $54 at BMO Capital
BMO Capital raised Azek's price target to $57 and maintains a Market Perform rating, citing benefits for shareholders. Truist suggests buying James Hardie post-Azek deal. Stephens downgraded Azek to Equal Weight.